Osteoporosis and the gynecologist: A call for action

Contemporary Ob-Gyn

Volumn 42, Issue 11, 1997, Pages 58-73

  Gass, Margery L S ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347706778     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Peck WA: Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646
2. Melton LJ III, Chrischilles EA, Cooper C, et al: How many women have osteoporosis? J Bone Miner Res 1992;7:1005
3. Riggs BL, Metton LG: Involutional osteoporosis. N Engl J Med 1986;314:1676
4. Looker AC, Johnston CC Jr, Heinz WW, et al: Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Min Res 1995;10:796
5. Kinsella KG, Taeuber CM: US Department of Commerce, Economics and Statistics Administration, Bureau of the Census, International Population Reports, P25, 92-3. An Aging World II. Washington DC: US Government Printing Office, 98-99; 1993
6. Kanis JA, Pitt FA: Epidemiology of osteoporosis. Bone 1992;13:(suppl)S7
7. Magaziner J, Simonsick GM, Koshner TM, et al: Predictors of functional recovery one year following hospital discharge for hip fracture: A prospective study. J Gerontol 1990;45:M101
8. Kanis JA, McCloskey EV: Epidemiology of vertebral osteoporosis. Bone 1992;13(suppl):S1
9. Melton LJ III: Hip fractures: A worldwide problem today and tomorrow. Bone 1993;14(suppl):S1
10. Johnston CC, Slemenda CW, Melton LS: Clinical use of bone densitometry. N Engl J Med 1991;324:1105
11. Cummings SR, Black DM, Nevitt MC, et al: Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72
12. World Health Organization: Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical Report, Geneva, Switzerland: series #843, 1994
13. US Congress, Office of Technology Assessment. Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy, vol 1: Cost-Effectiveness Analysis. Publication OTA-BP-H-160. Washington, DC: US Government Printing Office, August 1995
14. Hodgson SF, Johnston CC: AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis: American Association of Clinical Endocrinologists, March, 1996
15. Pouilles JM, Ribot C, Tremollieres F, et al: Risk factors of vertebral osteoporosis: Results of a study of 2,279 women referred to a menopause clinic. Rev Rhum Mal Osteoartic 1991;58:169
16. Cummings SR, Nevitt MC, Browner US, et al: Risk factors for hip fracture in white women. N Engl J Med 1995;332:767
17. Ettinger BF, Genant HK, Cann CE: Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319
18. Rubin SM, Cummings SR: Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990
19. Cauley JA, Seeley DG, Ensrud K, et al: Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9
20. Ettinger B, Genant HK, Steiger P, et al: Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 1992;166:479
21. Berman RS, Epstein RS, Lydick EG: Compliance of women taking estrogen replacement therapy. J Women's Health 1996;5:213
22. Ravnikar V: Compliance with hormone therapy. Am J Obstet Gynecol 1987;156:1332
23. Liberman UA, Weiss SR, Broll J, et al: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;22:1435
24. Chapuy MC: Vitamin D and calcium to prevent hip fracture in elderly women. N Engl J Med 1992;327:1637